Cabka Extraordinary General Meeting results: All resolutions duly passed
August 01, 2024 13:00 ET
|
Cabka N.V.
Amsterdam 01 August 2024. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport...
Alexander Masharov nominated for appointment as Chief Executive Officer of Cakba
May 02, 2024 02:00 ET
|
Cabka N.V.
Amsterdam 2 May 2024, 8 AM CET. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable...
BioNTech beruft Annemarie Hanekamp als Chief Commercial Officer in den Vorstand
March 20, 2024 06:00 ET
|
BioNTech SE
Mainz, Deutschland, 20. März 2024 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) gab heute bekannt, dass der Aufsichtsrat Annemarie Hanekamp mit Wirkung zum 1. Juli...
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
March 20, 2024 06:00 ET
|
BioNTech SE
Mainz, Germany, March 20, 2024 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Annemarie Hanekamp to the Management...
Cabka CEO Tim Litjens to step down by end September
March 19, 2024 13:45 ET
|
Cabka N.V.
Amsterdam 19 March 2024. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport...
BioNTech gibt geplanten Ruhestand von Sean Marett bekannt
March 07, 2024 06:45 ET
|
BioNTech SE
MAINZ, Deutschland, 7. März, 2024 – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder “das Unternehmen”) gab heute bekannt, dass Sean Marett, Chief Business and Commercial Officer, in den Ruhestand gehen und...
BioNTech Announces Planned Retirement of Sean Marett
March 07, 2024 06:45 ET
|
BioNTech SE
Mainz, Germany, March 7, 2024 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that Sean Marett, Chief Business and Commercial Officer, will retire as planned...
BioNTech erweitert Vorstand mit James Ryan als Chief Legal Officer
August 14, 2023 06:45 ET
|
BioNTech SE
MAINZ, Deutschland, 14. August 2023 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) gab bekannt, dass der Aufsichtsrat Dr. James Ryan mit Wirkung zum 1. September 2023 als Chief Legal...
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer
August 14, 2023 06:45 ET
|
BioNTech SE
MAINZ, Germany, August 14, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced that the Supervisory Board has appointed James Ryan, Ph.D., to the Management Board as Chief Legal...
Cabka starts year with strong growth in first quarter
April 25, 2023 01:30 ET
|
Cabka N.V.
Sales in the first quarter amounted to € 55.4 million up 11% Frank Roerink nominated to Management BoardAnnual Report 2022 published Amsterdam 25 April 2023. Cabka N.V. (together with its...